Deeper analysis revealed a pronounced upregulation of CD4+ T cells, CD8+ T cells, dendritic cells, and macrophages in the low-risk group, indicating an active and enhanced immune response within their tumor microenvironment. The gene discussed is CD8A; the disease is neoplasm.